The main difference between active and inactive MS is the presence of relapses. Read more about other differences in these forms of MS and their symptoms, diagnosis, and treatment.

Median time from randomization to first-line multiple myeloma treatment had not been reached in the daratumumab group vs. 50.2 months for the active monitoring group (HR = 0.46; 95% CI, 0.33-0.62).

SAN ANTONIO — Certain patients with low-risk ductal carcinoma can safely opt for active monitoring, according to study results presented at San Antonio Breast Cancer Symposium.An analysis of ...

Active monitoring vs. surgery and radiation. The standard of care for DCIS is surgery and radiation. Still, researchers have wondered if women truly benefit from this treatment, ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront ...

In the new study, 957 participants were randomized 1:1 to receive either guideline-concordant care (GCC) or active monitoring (AM) between June 2017 and January 2023, with stratification by age at ...